02.07.25 -- The Business Of CNS With Acumen's Jim Doherty, Ph.D.

Helen Sabzevari, Ph.D., President and CEO of Precigen, joins Cell & Gene: The Podcast to discuss how the company utilizes gorilla adenovirus vectors. These vectors offer significant advantages in delivering large genetic payloads, a crucial factor in developing effective gene therapies. Sabzevari also discusses Precigen's recent BLA submission for PRGN-2012, which includes Phase 1/2 pivotal study results where over 50% of patients achieved Complete Response and more than 85% experienced decreased surgical interventions. Listen now!

Community-based clinical trials enhance diversity, addressing mistrust and access barriers by fostering local partnerships, and accessible trial sites for underrepresented communities.

Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.

Clear benefits emerge when a trial master file is made a more engaging and less overwhelming task for all who must collaborate to complete it.

Senior Product Manager Iain Wood utilized his global expertise in managing clinical trial budgets, payments, and compliance to answer several questions about the complexities of site payments.

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.